GTP Bioways

📢 𝗕𝗶𝗴 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁! 📢 𝗚𝗧𝗣 𝗕𝗶𝗼𝘄𝗮𝘆𝘀 𝗝𝗼𝗶𝗻𝘀 𝗢𝗹𝗼𝗻 𝗚𝗿𝗼𝘂𝗽! We are thrilled to announce that GTP Bioways is now part of Olon Group! Together, we promise to deliver unparalleled development and manufacturing services to our biopharmaceutical customers 🌟 As Paolo Tubertini, CEO of Olon Group, stated, this union significantly enhances our capabilities. By joining Olon Group, we now provide end-to-end services to support your biopharmaceutical drug development journey from 𝗥&𝗗 𝘁𝗼 𝗺𝗮𝗿𝗸𝗲𝘁. 🧪➡️💊 Furthermore, GTP Bioways can now handle the entire 𝗔𝗗𝗖 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 process from start to finish, including the development and manufacturing of mAbs, linkers, payload, and conjugation. We can now offer a truly comprehensive ADC service. 🔗🔬 As we embark on this exciting journey together, stay tuned for more updates! 🎊 📄Check Olon's press release to learn more: https://lnkd.in/epyu_5Pq

🌟 𝗡𝗼𝘂𝘃𝗲𝗹𝗹𝗲 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗲́: 𝗧𝗲𝗰𝗵𝗻𝗶𝗰𝗶𝗲𝗻(𝗻𝗲) 𝗖𝗼𝗻𝘁𝗿𝗼̂𝗹𝗲 𝗤𝘂𝗮𝗹𝗶𝘁𝗲́ 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗾𝘂𝗲 🌟 Nous recherchons un(e) technicien(ne) en contrôle qualité biologique pour 𝗚𝗧𝗣 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 à 𝗦𝗮𝗶𝗻𝘁-𝗝𝘂𝗹𝗶𝗲𝗻-𝗲𝗻-𝗚𝗲𝗻𝗲𝘃𝗼𝗶𝘀. Dans ce rôle, vous serez responsable des contrôles biologiques et microbiologiques des produits issus de la bioproduction ainsi que des projets CDMO. Consultez la description complète du poste ici: https://lnkd.in/eqgEM7Kh 📌 𝗣𝗼𝘀𝘁𝗲 𝗮̀ 𝗽𝗼𝘂𝗿𝘃𝗼𝗶𝗿 𝗱𝗲̀𝘀 𝗾𝘂𝗲 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲 Prêts à rejoindre une équipe dynamique ? Explorez toutes nos offres d’emploi: https://lnkd.in/dbPsXVrQ

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗔𝘀𝗲𝗽𝘁𝗶𝗰 𝗙𝗶𝗹𝗹𝗶𝗻𝗴 - 𝗛𝗼𝘄 𝗜𝘀𝗼𝗹𝗮𝘁𝗼𝗿 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝘀 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 🔍 The integration of isolator technology marks a major leap forward in aseptic filling procedures. Historically, meeting aseptic standards depended on conventional production lines supported by surface bio-decontamination systems. 📝 Our article delves into the transformative power of isolator technology in aseptic filling. Learn how these advancements are reshaping processes, ensuring unmatched sterility assurance. #AsepticFilling #fillfinish 🔬

💉 𝗙𝗶𝗹𝗹(ed) 𝗮𝗻𝗱 𝗙𝗶𝗻𝗶𝘀𝗵(ed) 𝗙𝗿𝗶𝗱𝗮𝘆 – 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝘆𝗼𝘂𝗿 𝘃𝗶𝗿𝘁𝘂𝗮𝗹 𝘁𝗼𝘂𝗿! Take advantage of the opportunity to explore our 𝗙𝗶𝗹𝗹 & 𝗙𝗶𝗻𝗶𝘀𝗵 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗶𝗲𝘀 from the comfort of your own home! 😀 This is an incredible chance to visit a Class C/D zone, an area not easily accessible to the public, and witness first-hand the meticulous care we put into every detail. Join us for an exclusive virtual tour where you'll discover the state-of-the-art technology and processes that power our aseptic filling operations. Engage directly with our team, ask questions in real-time, and gain valuable insights into the industry-leading standards that uphold our pharmaceutical excellence. 😌 #GMP #asepticfilling #FillandFinish #manufacturing

❔ 𝗙𝗿𝗲𝗾𝘂𝗲𝗻𝘁𝗹𝘆 𝗔𝘀𝗸𝗲𝗱 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀 𝗔𝗯𝗼𝘂𝘁 𝗖𝗲𝗹𝗹 𝗟𝗶𝗻𝗲 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 ❔ Curious about the main cell lines used for stable antibody production? Wondering why CHO cells are preferred, or how long it takes to generate a stable cell line for antibody production? We've got all the answers you need! 📚 Explore Our 𝗙𝗔𝗤 𝗦𝗲𝗰𝘁𝗶𝗼𝗻 to Learn Everything About 𝗖𝗲𝗹𝗹 𝗟𝗶𝗻𝗲 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 and Our #CLD Services: https://lnkd.in/eAHzFgFR If you still have questions about Cell Line Development, feel free to ask us in the comments below. We would be happy to provide answers! #CHO #ProcessDevelopment

𝗚𝗧𝗣 𝗕𝗶𝗼𝘄𝗮𝘆𝘀 𝗶𝘀 𝗣𝗿𝗼𝘂𝗱 𝘁𝗼 𝗦𝘂𝗽𝗽𝗼𝗿𝘁 𝗔𝗱𝗮𝗽𝘁𝗩𝗮𝗰 💉 Pregnancy-associated malaria (PAM) is a relentless disease estimated to cause 20,000 maternal and 200,000 infant deaths annually. That’s why we wanted to highlight again how proud we are to support efforts to combat this devastating illness. 🤝 GTP Bioways is thrilled to support AdaptVac, a pioneering Danish biotech company, in manufacturing a GMP batch of their 𝗽𝗹𝗮𝗰𝗲𝗻𝘁𝗮𝗹 𝗺𝗮𝗹𝗮𝗿𝗶𝗮 vaccine, 𝗣𝗔𝗠𝗩𝗔𝗖, which is set to enter phase 1 clinical trials soon. AdaptVac has harnessed its unique capsid Virus-like Particle (cVLP) platform technology to develop PAMVAC, a vaccine designed to reduce the number of doses needed and enhance the longevity of the immune response. At GTP Bioways, we are excited to transfer this groundbreaking bioprocess into our state-of-the-art GMP facilities. Our role will include the production of the drug substance and the aseptic filling of the final product into vials.   Read more about this exciting development: https://lnkd.in/dzjDnDdP

🌟 𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗿𝗹𝗱 𝗬𝗼𝘂𝘁𝗵 𝗦𝗸𝗶𝗹𝗹𝘀 𝗗𝗮𝘆 🌟 Today, we celebrate 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗿𝗹𝗱 𝗬𝗼𝘂𝘁𝗵 𝗦𝗸𝗶𝗹𝗹𝘀 𝗗𝗮𝘆, a day dedicated to recognising and promoting the importance of equipping young people with the skills they need to thrive in the workplace and beyond. 🌍✨ At GTP Bioways, we wholeheartedly embrace the spirit of this day. We believe in providing young talents with opportunities not only to learn but also to apply their knowledge in real-world settings 🛠️. Through our #internship and #apprenticeship programmes, we strive to foster a supportive environment where young professionals can develop essential skills, gain valuable insights, and grow both personally and professionally. Today, as we reflect on the achievements of our interns and apprentices, we are inspired by their dedication and enthusiasm. Their contributions remind us of the limitless potential that lies within our youth when given the right tools and opportunities. 💪🌱 We extend our sincere gratitude to Emma Valentin, Clarisse Mandrou, Tânia De Freitas, Jade GABRIELI, Kenza Majber, Olivia KPOWBIE, Marine Lecoq, Muhammad Hakimi Bin Khairul Azuan and Pauline Foret for sharing their experiences. 🙏👏 🔍 Discover our opportunities here: https://lnkd.in/dbPsXVrQ

💡 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝘄𝗶𝘁𝗵 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆-𝗗𝗿𝘂𝗴 𝗖𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗲𝘀 (𝗔𝗗𝗖𝘀) 💡 Antibody-Drug Conjugates (ADCs) are transforming the landscape of cancer treatment, offering a groundbreaking approach by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. 🔍 𝗜𝗻 𝗧𝗵𝗶𝘀 𝗔𝗿𝘁𝗶𝗰𝗹𝗲, 𝗬𝗼𝘂’𝗹𝗹 𝗟𝗲𝗮𝗿𝗻 𝗔𝗯𝗼𝘂𝘁: ● The essential components of ADCs: monoclonal antibodies, linkers, and cytotoxic payloads. ● How ADCs precisely target cancer cells, minimising side effects and maximising efficacy. ● The current therapeutic applications of ADCs. ● The landscape of ADC developers in Europe. 📈 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗵𝗼𝘄 𝗔𝗗𝗖𝘀 𝗮𝗿𝗲 𝗿𝗲𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆

🌟 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗕𝗶𝗼𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗮𝗻𝗱 𝗕𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗗𝗮𝘆 𝗶𝗻 𝗧𝗼𝘂𝗹𝗼𝘂𝘀𝗲! 🌟 On July 5th, Just - Evotec Biologics, Flash BioSolutions and GTP Bioways, organised the 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗕𝗶𝗼𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗮𝗻𝗱 𝗕𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗗𝗮𝘆 (#JNBB2024) in Toulouse, an initiative by France BioLead. With support from Eurobiomed, Bio'Occ : projet Biothérapie et Bioproduction en Occitanie, and Leem, the event brought together over 130 participants. 🌍🔬 The day provided a valuable platform for students, educators and industry professionals to explore the biomanufacturing field. Interactive sessions and insightful discussions provided a unique opportunity to explore various careers in bioproduction and engage directly with experts from our companies. A special thanks to the GTP Bioways team members who contributed their expertise and time: Eric Devic, Carine Arcens, Nathalie Salin, and Samuel Hamdar. 👏🙌 We had the privilege of hosting esteemed guests Nadia Pellefigue, Vice-President for International and European Affairs, Research, and Higher Education for the Occitanie region, and Agnès Plagneux-Bertrand, Vice-President of Toulouse Métropole in charge of Industry. Their presence underscored the pivotal role of biomanufacturing in advancing healthcare innovations. We extend our sincere gratitude to everyone involved in organising the event, especially the dedicated teams from Just-Evotec Biologics, Flash Biosolutions, and GTP Bioways. To all participants, thank you for your enthusiasm and active participation. We look forward to seeing you again next year! 🎉

A 𝗵𝘂𝗴𝗲 𝘁𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝘁𝗼 𝗲𝗮𝗰𝗵 𝗮𝗻𝗱 𝗲𝘃𝗲𝗿𝘆 𝗼𝗻𝗲 𝗼𝗳 𝘆𝗼𝘂 for your continued support and engagement. Your trust and enthusiasm inspire us every day to push the boundaries in biopharmaceutical clinical development. At GTP Bioways, we are committed to providing unparalleled support to our clients and we are driven by customer-centric values of empathy, integrity, and transparency. 𝗬𝗼𝘂𝗿 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗶𝘀 𝗮 𝘁𝗲𝘀𝘁𝗮𝗺𝗲𝗻𝘁 𝘁𝗼 𝘁𝗵𝗲 𝗶𝗺𝗽𝗮𝗰𝘁 𝘄𝗲 𝗮𝗿𝗲 𝗺𝗮𝗸𝗶𝗻𝗴 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿. Thank you for being a part of our community.